LifeStance Health Group (NASDAQ:LFST) Announces Earnings Results

LifeStance Health Group (NASDAQ:LFST) released its earnings results on Thursday. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.05, Briefing.com reports. LifeStance Health Group had a negative return on equity of 10.51% and a negative net margin of 13.05%. The business had revenue of $312.70 million for the quarter, compared to analyst estimates of $302.25 million. During the same quarter last year, the firm posted ($0.17) earnings per share. The business’s revenue was up 18.9% compared to the same quarter last year. LifeStance Health Group updated its FY 2024 guidance to EPS and its Q4 2024 guidance to EPS.

LifeStance Health Group Trading Down 4.2 %

Shares of NASDAQ:LFST traded down $0.32 during midday trading on Friday, reaching $7.36. The company’s stock had a trading volume of 3,799,092 shares, compared to its average volume of 1,082,470. The firm has a market cap of $2.82 billion, a price-to-earnings ratio of -17.95 and a beta of 1.24. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.20. LifeStance Health Group has a 1 year low of $4.64 and a 1 year high of $9.20. The business has a 50 day moving average price of $6.92 and a 200 day moving average price of $6.21.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. UBS Group decreased their target price on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a report on Thursday, August 15th. Barclays lowered their price target on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a research note on Friday, August 9th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $8.25.

Insider Buying and Selling at LifeStance Health Group

In other news, insider Ann Varanakis sold 5,269 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $6.28, for a total value of $33,089.32. Following the completion of the sale, the insider now owns 263,007 shares of the company’s stock, valued at $1,651,683.96. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 6.60% of the stock is owned by company insiders.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.